7 alpha-hydroxy-4-cholesten-3-one has been researched along with Chronic Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Camilleri, M; Vijayvargiya, P | 1 |
| Amano, H; Furuie, H; Kumagai, Y; Maeda, M; Nakagawa, C; Oikawa, I; Sasaki, Y | 1 |
| Camilleri, M; Graffner, H; Holst, JJ; Rikner, L; Rudling, M | 1 |
| Walters, JR | 1 |
| Münzing, W; Paumgartner, G; Sauter, GH; von Ritter, C | 1 |
| Beuers, U; Büttner, J; Kullak-Ublick, GA; Oswald, M; Paumgartner, G; Rust, C; Sauter, GH | 1 |
2 review(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Chronic Disease
| Article | Year |
|---|---|
The Role of Bile Acids in Chronic Diarrhea.
Topics: Benzothiazoles; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestenones; Cholestyramine Resin; Chronic Disease; Colesevelam Hydrochloride; Colestipol; Diarrhea; Diet, Fat-Restricted; Feces; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Isoxazoles; Liver; Malabsorption Syndromes; Receptors, Cytoplasmic and Nuclear; Sequestering Agents; Taurocholic Acid | 2020 |
Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.
Topics: Bile Acids and Salts; Biomarkers; Cholestenones; Chronic Disease; Diagnosis, Differential; Diarrhea; Enterohepatic Circulation; Fibroblast Growth Factors; Humans; Malabsorption Syndromes; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Taurocholic Acid | 2010 |
2 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Chronic Disease
| Article | Year |
|---|---|
Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial.
Topics: Administration, Oral; Adult; Carrier Proteins; Cholestenones; Cholesterol, LDL; Chronic Disease; Constipation; Cross-Over Studies; Defecation; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Food-Drug Interactions; Humans; Ileum; Male; Membrane Glycoproteins; Middle Aged; Placebos; Sex Factors; Tablets; Thiazepines; Treatment Outcome; Young Adult | 2018 |
Specific inhibition of bile acid transport alters plasma lipids and GLP-1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Cholestenones; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Constipation; Dipeptides; Dyslipidemias; Female; Glucagon-Like Peptide 1; Humans; Lipids; Male; Middle Aged; Thiazepines; Triglycerides; Young Adult | 2015 |
2 other study(ies) available for 7 alpha-hydroxy-4-cholesten-3-one and Chronic Disease
| Article | Year |
|---|---|
Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum.
Topics: Adult; Bile Acids and Salts; Biomarkers; Cholestenones; Chronic Disease; Diarrhea; Female; Humans; Male; Middle Aged; Sensitivity and Specificity; Taurocholic Acid | 1999 |
Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.
Topics: Adult; Bile Acids and Salts; Cholestasis, Intrahepatic; Cholestenones; Cholestyramine Resin; Chronic Disease; Drug Administration Schedule; Drug Therapy, Combination; Fasting; Female; Humans; Male; Pruritus; Ursodeoxycholic Acid | 2000 |